Evaluation of a new immunoassay for determination of phenytoin and phenobarbital: results of a European collaborative control study.
The performance of a new enzyme multiplied immunoassay technique (EMIT) was compared with other current methods, namely gas-liquid chromatography and thin-layer chromatography, for the determination of phenytoin and phenobarbital in serum. Forty-three serum samples were sent as unknowns to the participating laboratories for determination. The precision of repeated determinations was very similar for EMIT and chromatography. There was good agreement among gas chromatography, thin-layer chromatography, and EMIT results. Interlaboratory variability was lower for EMIT determinations of both antiepileptic drugs. The rapid analysis of small samples, made possible by the EMIT system, could have beneficial effects on the treatment of epilepsies.
D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D005954:Glucosephosphate Dehydrogenase; D006801:Humans; D007118:Immunoassay; D007934:Leuconostoc / Q000201:enzymology; D010634:Phenobarbital / Q000097:blood*; D010672:Phenytoin / Q000097:blood*
D010672:Phenytoin; D005954:Glucosephosphate Dehydrogenase; D010634:Phenobarbital